Author Archives : Editorial Team

Home  >>  Author : Editorial Team

DKFZ: Levels of DNA tags characterize rare type of blood cancer

On January 8, 2018, Posted by , In News, With Comments Off on DKFZ: Levels of DNA tags characterize rare type of blood cancer

Not only genetic changes but also certain DNA tags play a role in the development of cancer. Scientists at the German Cancer Research Center (DKFZ) have discovered that leukemia of a specific type is extremely difficult to treat if the cancer cells contain very high levels of a certain type…

Logistik- und SAP-Kompetenz aus einer Hand: ParCon wird Teil von io-consultants

On January 8, 2018, Posted by , In News, With Comments Off on Logistik- und SAP-Kompetenz aus einer Hand: ParCon wird Teil von io-consultants

Heidelberg, 02.01.2018. Seit 1. Januar 2018 ist der SAP-Experte ParCon Consulting mit seinen Niederlassungen in Leonberg/Stuttgart und Berlin Teil des Beratungs- und Planungsunternehmens io-consultants mit Hauptsitz in Heidelberg. io-consultants baut dadurch seine Kompetenzen im Bereich SAP-Beratung aus und setzt ein deutliches Signal für weiteres Wachstum. Schon heute vereint io-consultants als…

DKFZ:Molecular super enhancers: A new key for targeted therapy of brain cancer in children

On December 31, 2017, Posted by , In News, With Comments Off on DKFZ:Molecular super enhancers: A new key for targeted therapy of brain cancer in children

Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer in children. The genetic causes for its development are largely unknown and there are no targeted treatments to date. Scientists from the “Hopp Children’s Cancer…

Roche: FDA approves Roche’s Perjeta (pertuzumab) for adjuvant treatment of specific type of early breast cancer

On December 31, 2017, Posted by , In News, With Comments Off on Roche: FDA approves Roche’s Perjeta (pertuzumab) for adjuvant treatment of specific type of early breast cancer

Accelerated approval of Perjeta for neoadjuvant use also converted to full approval Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the US Food and Drug Administration (FDA) has approved Perjeta® (pertuzumab), in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen), for adjuvant (after surgery) treatment of HER2-positive early breast…

Roche: European Commission approves Roche’s Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer

On December 31, 2017, Posted by , In News, With Comments Off on Roche: European Commission approves Roche’s Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer

Alecensa provides a new treatment option for people with newly diagnosed ALK-positive NSCLC Approval based on phase III ALEX data showing Alecensa reduced the risk of disease progression or death by more than half versus crizotinib Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has…

BioRN Network e.V. members assembly 2017: Entering a new era of excellence

On December 18, 2017, Posted by , In News, With Comments Off on BioRN Network e.V. members assembly 2017: Entering a new era of excellence

Heidelberg (D)|The BioRN Network e.V. members came together on December 11th, 2017 to set the future path for the BioRN Network. The decisions made during the members assembly emanate from extensive work on the thematic focus, strategy and composition of the cluster over the past year. Together with the elections…

BioRN: Funding approval for the development and validation of the Health Axis Europe Partnering Platform (HAEPP)

On December 15, 2017, Posted by , In News, With Comments Off on BioRN: Funding approval for the development and validation of the Health Axis Europe Partnering Platform (HAEPP)

Heidelberg (D) | BioRN, together with its project partners, has been successful with its application within the call „Internationalisierung von Spitzenclustern, Zukunftsprojekten und vergleichbaren Netzwerken“ (Clusters – Networks – International) from the Federal Ministry of Education and Research (BMBF). The HAEPP project aims to bundle the innovative strengths of science…

Heidelberg University: Automatic Cell Tracking in Microscopy Images

On December 14, 2017, Posted by , In News, With Comments Off on Heidelberg University: Automatic Cell Tracking in Microscopy Images

Heidelberg researchers develop powerful image analysis method Source: Karl Rohr / Nathalie Harder (BMCV) Tracking result for a large number of cells: The movement paths of individual cells are shown in different colours. Researchers from Heidelberg University and the German Cancer Research Center have developed a new computer-based image analysis…

DKFZ: Impaired path integration in mice with disrupted grid cell firing

On December 13, 2017, Posted by , In News, With Comments Off on DKFZ: Impaired path integration in mice with disrupted grid cell firing

The direct route from A to C We use special nerve cells for spatial orientation. The place cells fire whenever we stay in a particular place. The grid cells, on the other hand, measure distances and play a crucial role in “path integration”. So much for the theory. Scientists from…

Sanofi: FDA Approves Sanofi’s Admelog® (insulin lispro injection)

On December 13, 2017, Posted by , In News, With Comments Off on Sanofi: FDA Approves Sanofi’s Admelog® (insulin lispro injection)

First FDA-approved follow-on mealtime insulin Admelog (insulin lispro injection) 100 Units/mL will be available in U.S. in vial and SoloStar pen Paris, France – December 11, 2017 – The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Admelog®, the first follow-on insulin lispro to help people living with diabetes…